Back to Search Start Over

Dual targeting of mTOR/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation

Authors :
Roy, Tithi
Banang-Mbeumi, Sergette
Boateng, Samuel T.
Ruiz, Emmanuelle M.
Chamcheu, Roxane-Cherille N.
Kang, Lin
King, Judy A.
Walker, Anthony L.
Nagalo, Bolni Marius
Kousoulas, Konstantin G.
Esnault, Stephane
Huang, Shile
Chamcheu, Jean Christopher
Roy, Tithi
Banang-Mbeumi, Sergette
Boateng, Samuel T.
Ruiz, Emmanuelle M.
Chamcheu, Roxane-Cherille N.
Kang, Lin
King, Judy A.
Walker, Anthony L.
Nagalo, Bolni Marius
Kousoulas, Konstantin G.
Esnault, Stephane
Huang, Shile
Chamcheu, Jean Christopher
Publication Year :
2023

Abstract

Psoriasis is a chronic autoimmune inflammatory skin disorder characterized by epidermal hyperplasia and aberrant immune response. In addition to aberrant cytokine production, psoriasis is associated with activation of the Akt/mTOR pathway. mTOR/S6K1 regulates T-lymphocyte activation and migration, keratinocytes proliferation and is upregulated in psoriatic lesions. Several drugs that target Th1/Th17 cytokines or their receptors have been approved for treating psoriasis in humans with variable results necessitating improved therapies. Fisetin, a natural dietary polyphenol with anti-oxidant and anti-proliferative properties, covalently binds mTOR/S6K1. The effects of fisetin on psoriasis and its underlying mechanisms have not been clearly defined. Here, we evaluated the immunomodulatory effects of fisetin on Th1/Th17-cytokine-activated adult human epidermal keratinocytes (HEKa) and anti-CD3/CD28-stimulated inflammatory CD4(+) T cells and compared these activities with those of rapamycin (an mTOR inhibitor). Transcriptomic analysis of HEKa revealed 12,713 differentially expressed genes (DEGs) in the fisetin-treated group compared to 7,374 DEGs in the rapamycin-treated group, both individually compared to a cytokine treated group. Gene ontology analysis revealed enriched functional groups related to PI3K/Akt/mTOR signaling pathways, psoriasis, and epidermal development. Using in silico molecular modeling, we observed a high binding affinity of fisetin to IL-17A. In vitro, fisetin significantly inhibited mTOR activity, increased the expression of autophagy markers LC3A/B and Atg5 in HEKa cells and suppressed the secretion of IL-17A by activated CD4(+) T lymphocytes or T lymphocytes co-cultured with HEKa. Topical administration of fisetin in an imiquimod (IMQ)-induced mouse psoriasis model exhibited a better effect than rapamycin in reducing psoriasis-like inflammation and Akt/mTOR phosphorylation and promoting keratinocyte differentiation and autophagy in mice skin lesio

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1375352612
Document Type :
Electronic Resource